Its ability to predict mortality in heart failure patients has been described in various studies, including those conducted by Ceconi et al., which demonstrated a strong correlation between plasma CgA levels and disease severity, suggesting its use in clinical risk stratification [19]. The gene discussed is CGA; the disease is heart failure.